Cargando…

Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice

Enterovirus 71 (EV71) infection is known to cause hand, foot, and mouth disease (HFMD), which is associated with neurological complications; however, there is currently no effective treatment for this infection. Flavonoids are a large group of naturally occurring compounds with multiple bioactivitie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Wenwen, Bi, Jinpeng, Li, Fang, Wang, Shuai, Huang, Xinyu, Meng, Xiangyu, Sun, Bo, Wang, Deli, Kong, Wei, Jiang, Chunlai, Su, Weiheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669683/ https://www.ncbi.nlm.nih.gov/pubmed/31284698 http://dx.doi.org/10.3390/v11070625

Ejemplares similares

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro
por: Li, Xiang, et al.
Publicado: (2015)

Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo
por: Dai, Wenwen, et al.
Publicado: (2018)

Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection in vitro and in vivo
por: Huang, Xinyu, et al.
Publicado: (2022)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo
por: Chen, Sin-Guang, et al.
Publicado: (2017)

Strategies to develop antivirals against enterovirus 71
por: Kuo, Rei-Lin, et al.
Publicado: (2013)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Enterovirus A71 antivirals: Past, present, and future
por: Wang, Jun, et al.
Publicado: (2022)

Identification of a Common Epitope between Enterovirus 71 and Human MED25 Proteins Which May Explain Virus-Associated Neurological Disease
por: Fan, Peihu, et al.
Publicado: (2015)

Correction: Lalani, S. and Poh, C.L. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses 2020, 12, 184
por: Lalani, Salima, et al.
Publicado: (2020)

Characterization of human enterovirus71 virus-like particles used for vaccine antigens
por: Zhao, Dandan, et al.
Publicado: (2017)

Antiviral Effect of Matrine against Human Enterovirus 71
por: Yang, Yajun, et al.
Publicado: (2012)

Developments towards antiviral therapies against enterovirus 71
por: Wu, Kan X., et al.
Publicado: (2010)

Antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro
por: Zhang, Y., et al.
Publicado: (2017)

Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G
por: Li, Zhaolong, et al.
Publicado: (2018)

Enzymatic Biotransformation of Gypenoside XLIX into Gylongiposide I and Their Antiviral Roles against Enterovirus 71 In Vitro
por: Zhao, Huanxi, et al.
Publicado: (2022)

Curcumin inhibits the replication of enterovirus 71 in vitro
por: Qin, Ying, et al.
Publicado: (2014)

Recent developments in antiviral agents against enterovirus 71 infection
por: Tan, Chee Wah, et al.
Publicado: (2014)

Antiviral and Inflammatory Cellular Signaling Associated with Enterovirus 71 Infection
por: Jin, Yuefei, et al.
Publicado: (2018)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2021)

Human enterovirus 71 protein interaction network prompts antiviral drug repositioning
por: Han, Lu, et al.
Publicado: (2017)

Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
por: Xu, Lin, et al.
Publicado: (2014)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71
por: Tan, Jie Kai, et al.
Publicado: (2022)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Structure activity relationship of novel antiviral nucleosides against Enterovirus A71
por: Tosh, Dilip K., et al.
Publicado: (2020)

Chlorogenic Acid Inhibits the Replication and Viability of Enterovirus 71 In Vitro
por: Li, Xiang, et al.
Publicado: (2013)

Seroepidemiology of Human Enterovirus 71, Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2002)

Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71
por: Yang, Yajun, et al.
Publicado: (2013)

Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model
por: Lei, Li, et al.
Publicado: (2021)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)

Recombinant Human Enterovirus 71
Publicado: (2004)

The cellular receptor for enterovirus 71
por: Liu, Yue, et al.
Publicado: (2014)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Analysis of the Complete Genomes of Enterovirus 71 Subtypes in China
por: Wang, Lei, et al.
Publicado: (2021)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2
por: Li, Xiaojun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mf7uq40jrh21qgsgfcumcj3utp